[ad_1]
An expensive anti-cancer drug that treats an aggressive form of lymphoma will be subsidized starting next month, which will make it affordable for hundreds of patients
Imbruvica drug is used to treat mantle lymphoma when there is relapse after chemotherapy. Federal Health Minister Greg Hunt announced that as of August 1, Imbruvica would be available through the Pharmaceutical Benefits Program.
He will join three other drugs that treat head and neck cancer, blood cancer and the side effects of chemotherapy.
"Its total cost of $ 250 million will help save and protect thousands of patients Mr. Hunt told reporters today in Melbourne
" This will allow families to have the life saves or change their lives. "
"I hope that there will be many families who will be able to give a great sigh of relief, a sigh of relief for financial reasons, but especially for health reasons."
four drugs are expected to help between 4,000 and 5,000 people a year, said Hunt
. Imbruvica in a clinical trial in Melbourne and said the drug worked by targeting a gene that cancer needs to survive, but the rest of the body does not need it.
Patient Ertugrul Delibalta is a 70-year-old retiree who was diagnosed for the first time six years ago and relapsed after about three years
"They said we can no longer do Chemotherapy "If we do chemotherapy again, we kill you," Delibalta told the press.
Mr. Delibalta said that he had been put to the test of Dr. Tam because "it would have been too hard and I would have died" he had to pay for the drug.
© Nine Digital Pty Ltd 2018
[ad_2]
Source link
